|Venture capital fund, 2/11||$100M|
Osage University Partners (“OUP”) is a new venture capital fund that invests in university start-ups. OUP partners with high quality universities to serve as their coinvestment vehicle in start-ups that are licensing their technology.
|Effector Therapeutics||5/13||Series A||$45M||7|
|Applied Genetics Technologies Corporation||11/12||Series B||$37.5M||6|
|Mirna Therapeutics||10/12||Series C||$34.5M||5|
|SolarBridge Technologies||5/12||Series D||$25M||3|
|Avid Radiopharmaceuticals||5/09||Series D||$34.5M||8|